Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Pamidronate prevents chemotherapy-induced bone loss in premenopausal women
July 21st, 2005
Pamidronate prevents chemotherapy-induced bone loss in premenopausal women, researchers report. "Mortality from breast cancer has decreased in large part because of adjuvant chemotherapy. Sequelae of therapy include ovarian failure and bone loss - loss that would increase these patients' risk of fracture with aging," wrote G.E.H. Fuleihan and colleagues, American University of Beirut, who conducted a study of "the efficacy of pamidronate in preventing such loss." "The study was a 1-year randomized, double-blind, placebo-controlled trial comparing pamidronate 60 mg intravenously every 3 months with placebo in 40 premenopausal women with newly...
Source: Women's Health Weekly (2005-07-21)
|
